Literature DB >> 28610776

Two-stage late reconstruction with a fresh large osteochondral shell allograft transplantation (FLOCSAT) for a large ostechondral defect in a non-union after a lateral tibia plateau fracture 2-year follow up.

C Krettek1, J Clausen2, M Omar2, S Noack2, C Neunaber2.   

Abstract

This is the description of a 58-year-old female patient presenting 8 months after a horse riding accident with significant pain and inability to walk independently. Imaging revealed a large osseous defect of the lateral tibia plateau which was not united posteriorly. The patient refused knee replacement and we developed a patient specific two-step procedure for her. Step 1: Filling of the defect with a large cortico-cancellous autograft from the posterior iliac crest; step 2: Transplantation of a fresh large osteochondral shell allograft (FLOCSAT). The postoperative protocol included continuous passive motion (CPM), partial weight bearing for three months, and physiotherapy. Based on the concept of immuno-privileged cartilage tissue, the patient did not get any immuno-suppressive therapy. Pain-, activity of daily living, Lysholm and Tegner scores were evaluated before defect filling surgery with autograft, before allograft transplantation, and at 12 and 24 months after allograft transplantation. There were no complications. Radiographic analyses with plain films and CT scans revealed solid osseous integration within 3 month. The patient regained excellent functionality in both, activities of daily living and sports (back to horse riding, trampolin jumping). Knee arthroscopy after 1year showed excellent condition of the lateral meniscus and the cartilage of the lateral tibia plateau. Chimerism/DNA analysis of a cartilage biopsy showed, that at 1year 32% of the donor cells have been already replaced by the patient's own cells. To our knowledge, this is the first case of a patient who sustained such a large defect during a tibia plateau fracture, and got successfully treated with a fresh large osteochondral shell allograft transplantation in a two-step procedure.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cartilage transplantation; Chimerism/DNA analysis; Fresh cartilage; Late reconstruction; Living cartilage; Malalignment; Osteochondral allograft; Osteochondral defect; Tibia plateau; Tissue transplantation

Mesh:

Year:  2017        PMID: 28610776     DOI: 10.1016/j.injury.2017.05.010

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

Review 1.  [Partial and complete joint transplantation with fresh osteochondral allografts-the FLOCSAT concept].

Authors:  C Krettek; J-D Clausen; N Bruns; C Neunaber
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

Review 2.  [Complex joint reconstruction and joint transplantation with the FLOCSAT concept-planning and surgical implementation].

Authors:  C Krettek; J-D Clausen; C Neunaber
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

3.  Two-stage bone and meniscus allograft and autologous chondrocytes implant for unicompartmental osteoarthritis: midterm results.

Authors:  E Álvarez-Lozano; D Luna-Pizarro; G Meraz-Lares; R Quintanilla-Loredo; M V Cerdá-García; F Forriol
Journal:  Musculoskelet Surg       Date:  2020-08-26

4.  Use of Osteochondral and Meniscal Allografts from Bone Cuts of Total Knee Arthroplasty for the Treatment of Tibial Plateau Malunions: A Case Series of Four Patients Showing Early Results.

Authors:  Tarun Goyal; Souvik Paul; Arghya Kundu Choudhury; V Abdusamad
Journal:  Indian J Orthop       Date:  2021-01-28       Impact factor: 1.251

Review 5.  Allogeneic mesenchymal stromal cells for cartilage regeneration: A review of in vitro evaluation, clinical experience, and translational opportunities.

Authors:  Ellison D Aldrich; Xiaolin Cui; Caroline A Murphy; Khoon S Lim; Gary J Hooper; C Wayne McIlwraith; Tim B F Woodfield
Journal:  Stem Cells Transl Med       Date:  2021-08-13       Impact factor: 6.940

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.